| |
n
|
Avg age of onset
|
Avg age at death
|
Avg disease duration
|
% female
|
Avg PMI
|
|---|
|
Normal – age-matched
|
15
|
N/A
|
71.7(8.4)
|
N/A
|
46.7
|
12.7(8.5)
|
|
Normal – non age-matched
|
12
|
N/A
|
54.5(24.9)
|
N/A
|
66.7
|
9.1(3.4)
|
|
Normal - total
|
27
|
N/A
|
64.0(19.4)
|
N/A
|
56.7
|
11.1(6.9)
|
|
PSP
|
17
|
66.8(5.8)
|
73.7(5.2)
|
6. 7(2.2)
|
64.7
|
11.7(6.0)
|
|
AD
|
9
|
65.0(6.3)
|
75.8(5.1)
|
10. 8(3.4)
|
44.4
|
9.4(5.8)
|
- There were no significant differences between groups for average age at death (ANOVA, p = 0.33), post-mortem interval (ANOVA, p = 0.54), average age of onset (PSP and AD only, Student’s t-test, p = .45) or percent female (Chi Square, p = 0.89). Average disease duration for AD was significantly longer than for PSP (Student’s t-test, p = 0.002). Standard deviations indicated inside parenthesis.
